The Inflammation-Mediated Bidirectional Relationship Between Cardiovascular Disease and Cancer
"Cancer and atherosclerotic cardiovascular disease (ASCVD) represent two of the leading causes of death worldwide... Targeting shared pathways using statins, colchicine, canakinumab, IL-6 inhibition, and lifestyle modification may provide dual benefits."
CV inflammation leaves a trail, test hsCRP to find it. ESC/EAS and ACC/AHA guidelines recognise hsCRP as a biomarker of inflammation in CV risk assessment.1,2 Find out more about the latest guideline updates at ESC Hall A2 Stand T100.
Obesity and cardiovascular inflammation remain urgent challenges. At ESC Congress 2026, we're spotlighting science that drives innovation - and lasting health.
The POSEIDON study found that CV inflammation remained prevalent despite standard of care and despite the presence of comorbid hypertension or T2D. Identify inflammatory risk by testing hsCRP.
Neuroimmune crosstalk in the lungs induces eosinophil recruitment and type 2 inflammation via norepinephrine, which could drive sex differences in allergic asthma in mice.
Learn more in @SciImmunology: